Flow cytometric detection of accelerated telomere shortening in myelodysplastic syndromes: correlations with aetiological and clinical-biological findings*
- 30 September 2004
- journal article
- Published by Wiley in European Journal of Haematology
- Vol. 73 (5) , 351-358
- https://doi.org/10.1111/j.1600-0609.2004.00305.x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Telomeres, stem cells, senescence, and cancerJournal of Clinical Investigation, 2004
- Telomere maintenance and diseaseThe Lancet, 2003
- More cell death in refractory anemia with excess blasts in transformation than in acute myeloid leukemiaLeukemia, 2002
- The World Health Organization (WHO) classification of the myeloid neoplasmsBlood, 2002
- Myelodysplastic syndrome is not merely “preleukemia”Blood, 2002
- Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndromeBlood, 2001
- The role of apoptosis, proliferation, and the Bcl-2–related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDSBlood, 2000
- MyelodysplasiaNew England Journal of Medicine, 1999
- Telomere reduction in human colorectal carcinoma and with ageingNature, 1990
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982